Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChR
    (2)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Endocrine system
    (2)
Filter
Search Result
Results for "

guanylyl imidodiphosphate

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
  • Oligonucleotides
    1
    TargetMol | All_Pathways
  • Guanylyl Imidodiphosphate
    T21803148892-91-5
    Guanylyl Imidodiphosphate trisodium (Guanosine 5'-[β,γ-imido]triphosphate), a non-hydrolysable GTP analogue, activates ADP-ribosylation factor (ARF) and strongly stimulates adenylate cyclase. It is utilized in protein synthesis studies [1] [2] [3].
    • $1,520
    6-8 weeks
    Size
    QTY
  • Guanylyl Imidodiphosphate (lithium salt)
    T3600964564-03-0
    Guanylyl Imidodiphosphate (lithium salt) is a non-hydrolyzable GTP analog that increases adenylate cyclase activity.
    • $168
    35 days
    Size
    QTY
  • Neuromedin C (trifluoroacetate salt)
    T35669
    Neuromedin C is a bombesin-like neuropeptide that stimulates uterine smooth muscle contraction and the release of gastrin , somatostatin, and amylase in rats. Neuromedin C is a truncated form of gastrin-releasing peptide corresponding to the GRP amino acids 18-27. It inhibits GRP and bombesin binding to rat pancreatic membranes (IC50s = 0.4 and 2.2 nM, respectively), which can be reduced by sodium chloride and guanylyl imidodiphosphate . Neuromedin C induces scratching and mast cell degranulation in mice when administered intradermally at doses ranging from 1 to 300 nmol/site, which is inhibited by the BB2 bombesin receptor agonist RC-3095 and reduced in mast cell-deficient mice. Neuromedin C (3.2 nmol/kg, i.p.) reduces rat glucose consumption by approximately 50% for up to one hour.
    • $366
    35 days
    Size
    QTY